Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

https://www.soho2020.com/

Basic Science
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
Events

Playback speed

10 seconds

2020 SOHO Update on IDH Inhibitors in MDS: How Common Are IDH 1/2 Mutations in MDS & What Are They Associated With? Is There Any Activity With Ivosidenib and Enasidenib?

By Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020) FEATURING Courtney D. DiNardo

17 views

December 11, 2020

Comments 0

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

MDS and MPN

2020 SOHO Update on MDS: Characteristics and Outcomes of SF3B1 Mutat…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

V. Volpe

164 views

2020 SOHO Update on IDH Inhibitors in MDS: How Common Are IDH 1/2 Mu…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

C. DiNardo

17 views

2020 SOHO Updates on Anemia in MDS: How Does Luspatercept Affect RBC…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

U. Platzbecker

154 views

2020 SOHO Updates on Oral HMAs in MDS: Can FDA-Approved Decitabine/C…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

G. Garcia-Manero

165 views

2020 SOHO Updates on MDS: What Is the Safety and Efficacy of Ven+Aza…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

A. Zeidan

127 views

2020 SOHO Updates on TP53 in MDS: What Is the Correlation of VAF and…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

D. Sallman

139 views

2020 SOHO Updates on MDS: How Do TP53 Mutations Impact Prognosis in …

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

D. Sallman

15 views

2020 SOHO Updates on ET: What Does the Diagnostic Algorithm Look Lik…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

A. Tefferi

76 views

Next Questions in MF in 2020: What Is MIPSS70-Plus Risk Score? What …

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

P. Bose

24 views

2020 SOHO Updates on MDS: What Is the Proposed Treatment Algorithm f…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

G. Garcia-Manero

21 views

2020 SOHO Highlights on Myelofibrosis: What Is the Distinctive Featu…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

R. Rampal

358 views

2020 SOHO Highlights on Myelofibrosis: How Can We Improve Survival A…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

U. Popat

151 views

2020 SOHO Updates on Myelofibrosis: What Are the Long-Term Outcomes …

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

J. Joseph

104 views

73 y/o Male With Polycythemia Vera With JAK2 V617F Mutation: How Doe…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

L. Michaelis

65 views

34 y/o Female With JAK2 V617F Mutated Polycythemia Vera: What PV Tre…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

G. Hobbs

181 views

2020 SOHO Updates on Myelofibrosis: What Are the Response Rates With…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

S. Verstovsek

157 views